OpenAI released GPT-Rosalind, a reasoning model tailored for genomics and protein analysis. The system targets drug discovery and complex scientific workflows. By specializing in biological data, it moves beyond general-purpose LLMs. Researchers can now automate high-level reasoning tasks in life sciences to accelerate lab discovery cycles and genomic mapping.